GLUL and pancreatic neoplasm: In addition, studies have shown that mTORC1 and other substances can affect glutamine synthetase to inhibit the synthesis of glutamine, further inhibit the nutrient uptake of pancreatic cancer cells, and reduce the proliferation ability of PDAC (48).